These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29956442)

  • 1. An online self-test added to colorectal cancer screening can increase the effectiveness of familial cancer risk assessment without increasing distress.
    van Erkelens A; Sie AS; Spanier MBW; van Kouwen M; Visser A; Prins JB; Hoogerbrugge N
    Colorectal Dis; 2018 Oct; 20(10):897-904. PubMed ID: 29956442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Online self-test identifies women at high familial breast cancer risk in population-based breast cancer screening without inducing anxiety or distress.
    van Erkelens A; Sie AS; Manders P; Visser A; Duijm LE; Mann RM; Ten Voorde M; Kroeze H; Prins JB; Hoogerbrugge N
    Eur J Cancer; 2017 Jun; 78():45-52. PubMed ID: 28412588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
    Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
    Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an online family history tool for identifying hereditary and familial colorectal cancer.
    Kallenberg FGJ; Aalfs CM; The FO; Wientjes CA; Depla AC; Mundt MW; Bossuyt PMM; Dekker E
    Fam Cancer; 2018 Jul; 17(3):371-380. PubMed ID: 28936633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal screening using the immunochemical faecal occult blood test kit among the Malaysian cohort participants.
    Abdullah N; Abd Jalal N; Ismail N; Kamaruddin MA; Abd Mutalib NS; Alias MR; Mazlan L; Sagap I; Jamal R
    Cancer Epidemiol; 2020 Apr; 65():101656. PubMed ID: 31923638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR.
    Hoffmann S; Crispin A; Lindoerfer D; Sroczynski G; Siebert U; Mansmann U; Consortium F
    BMC Gastroenterol; 2020 May; 20(1):131. PubMed ID: 32370777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial consequences of receiving false-positive colorectal cancer screening results: a qualitative study.
    Toft EL; Kaae SE; Malmqvist J; Brodersen J
    Scand J Prim Health Care; 2019 Jun; 37(2):145-154. PubMed ID: 31079520
    [No Abstract]   [Full Text] [Related]  

  • 8. Validation of an online questionnaire for identifying people at risk of familial and hereditary colorectal cancer.
    Kallenberg FG; IJspeert JE; Bossuyt PM; Aalfs CM; Dekker E
    Fam Cancer; 2015 Sep; 14(3):401-10. PubMed ID: 25800523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological effects of colorectal cancer screening: Participants
    Kirkøen B; Berstad P; Botteri E; Bernklev L; El-Safadi B; Hoff G; de Lange T; Bernklev T
    World J Gastroenterol; 2016 Nov; 22(43):9631-9641. PubMed ID: 27920484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revised Australian national guidelines for colorectal cancer screening: family history.
    Jenkins MA; Ait Ouakrim D; Boussioutas A; Hopper JL; Ee HC; Emery JD; Macrae FA; Chetcuti A; Wuellner L; St John DJB
    Med J Aust; 2018 Nov; 209(10):455-460. PubMed ID: 30359558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer screening in first-degree relatives of colorectal cancer: participation, knowledge, and barriers against screening.
    Gimeno García AZ; Quintero E; Nicolás Pérez D; Hernández M; JiménezSosa A
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1165-71. PubMed ID: 21989122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys.
    Wong MC; John GK; Hirai HW; Lam TY; Luk AK; Ching JY; Ng SS; Chan FK; Griffiths SM; Sung JJ
    Cancer Causes Control; 2012 Sep; 23(9):1541-8. PubMed ID: 22836914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Can an online risk assessment tool for identification of hereditary colorectal cancer reach the at-risk population and influence screening compliance?].
    Schürmanns K; Gelos M; Felder G; Schneider R; Möslein G
    Dtsch Med Wochenschr; 2014 May; 139(18):935-40. PubMed ID: 24760714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Family History and Genetic Testing to Determine Risk of Colorectal Cancer.
    Kastrinos F; Samadder NJ; Burt RW
    Gastroenterology; 2020 Jan; 158(2):389-403. PubMed ID: 31759928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-sectional study.
    Siebenhofer A; Plath J; Taubenroth M; Singer S; Hechtner M; Dahlhaus A; Rauck S; Schulz-Rothe S; Koné I; Gerlach FM
    BMC Cancer; 2015 Aug; 15():605. PubMed ID: 26314581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.
    Stoffel EM; Mangu PB; Gruber SB; Hamilton SR; Kalady MF; Lau MW; Lu KH; Roach N; Limburg PJ; ;
    J Clin Oncol; 2015 Jan; 33(2):209-17. PubMed ID: 25452455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decentralized colonoscopic surveillance with high patient compliance prevents hereditary and familial colorectal cancer.
    Sjöström O; Lindholm L; Tavelin B; Melin B
    Fam Cancer; 2016 Oct; 15(4):543-51. PubMed ID: 26935832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are anxiety levels associated with the decision to participate in a Swedish colorectal cancer screening programme? A nationwide cross-sectional study.
    Wangmar J; von Vogelsang AC; Hultcrantz R; Fritzell K; Wengström Y; Jervaeus A
    BMJ Open; 2018 Dec; 8(12):e025109. PubMed ID: 30580275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.